Hepatitis C remains leading indication for listings and receipt of liver transplantation for hepatocellular carcinoma
With the availability of direct acting antivirals (DAA) for hepatitis C virus (HCV) infection, alcoholic liver disease (ALD) has evolved as the leading indication for listing and receipt of liver transplantation (LT) followed by non-alcoholic steatohepatitis and HCV infection. However, data are limited on etiology specific trends on listings and need for LT for hepatocellular carcinoma (HCC).
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: Ashwani K. Singal, Sanjaya K. Satapathy, Nancy Reau, Robert Wong, Yong-Fang Kuo Tags: Liver, Pancreas and Biliary Tract Source Type: research
More News: Alcoholism | Cancer & Oncology | Carcinoma | Gastroenterology | Hepatitis | Hepatitis C | Hepatocellular Carcinoma | Liver | Liver Cancer | Liver Disease | Liver Transplant | Pancreas | Pancreatic Cancer | Transplants | Urology & Nephrology